Literature DB >> 7044627

Generation of a monoclonal antibody against facteur thymique serique (FTS).

K Ohga, G S Incefy, C Y Wang, R A Good.   

Abstract

A monoclonal antibody against one of the thymic hormones, facteur thymique serique (FTS), was generated by hybridization between mouse NS-1 myeloma cells and BALB/c splenocytes, the latter obtained from BALB/c mice immunized with synthetic FTS coupled to mouse IgG. Enzyme-linked immunosorbent assay (ELISA) was developed and employed to detect the hybridoma secreting specific antibody. The monoclonal antibody (MA-FTS) was highly specific for FTS and did not cross-react with other thymic hormones or other unrelated peptides. MA-FTS could recognize FTS (or FTS-like molecule) in human serum and could absorb completely the FTS-like activity from human serum.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7044627      PMCID: PMC1536426     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

Review 1.  The mode of action of thymic hormones.

Authors:  J F Bach; M A Bach; J Charreire; M Dardenne; J M Pleau
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

2.  Biochemical characterisation of a serum thymic factor.

Authors:  J Bach; M Bardenne; J Pleau; J Rosa
Journal:  Nature       Date:  1977-03-03       Impact factor: 49.962

3.  Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide.

Authors:  A L Goldstein; T L Low; M McAdoo; J McClure; G B Thurman; J Rossio; C Y Lai; D Chang; S S Wang; C Harvey; A H Ramel; J Meienhofer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

4.  Circulating thymic factor, facteur thymique serique (FTS), in mycosis fungoides and Sezary syndrome.

Authors:  B Safai; M Dardenne; G S Incefy; J F Bach; R A Good
Journal:  Clin Immunol Immunopathol       Date:  1979-08

5.  Structural study of circulating thymic factor: a peptide isolated from pig serum. I. Isolation and purification.

Authors:  M Dardenne; J M Pleau; N K Man; J F Bach
Journal:  J Biol Chem       Date:  1977-11-25       Impact factor: 5.157

6.  Bioassay determinations of thymopoietin and thymic hormone levels in human plasma.

Authors:  J J Twomey; G Goldstein; V M Lewis; P M Bealmear; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

7.  Circulating thymic hormone activity in patients with primary and secondary immunodeficiency diseases.

Authors:  T Iwata; G S Incefy; S Cunningham-Rundles; C Cunningham-Rundles; E Smithwick; N Geller; R O'Reilly; R A Good
Journal:  Am J Med       Date:  1981-09       Impact factor: 4.965

8.  Interaction between thymopoietin and facteur thymique serique in the rosette inhibition assay.

Authors:  T Iwata; G S Incefy; R A Good
Journal:  Biochem Biophys Res Commun       Date:  1979-06-27       Impact factor: 3.575

9.  Thymic hormone-like restoration by human prealbumin of azathioprine sensitivity of spleen cells from thymectomized mice.

Authors:  P Burton; S Iden; K Mitchell; A White
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

10.  Evidence of the presence in normal serum of a carrier of the serum thymic factor (FTS).

Authors:  M Dardenne; J M Pléau; J F Bach
Journal:  Eur J Immunol       Date:  1980-02       Impact factor: 5.532

View more
  2 in total

1.  A zinc-dependent epitope on the molecule of thymulin, a thymic hormone.

Authors:  M Dardenne; W Savino; S Berrih; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Growth hormone treatment stimulates thymulin production in aged dogs.

Authors:  B L Goff; J A Roth; L H Arp; G S Incefy
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.